LZAGF (Lonza Group) EBIT : $921 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Lonza Group EBIT?

Lonza Group's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was $508 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was $921 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Lonza Group's annualized ROC % for the quarter that ended in Jun. 2024 was 6.51%. Lonza Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 11.85%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Lonza Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 1.97%.

Lonza Group EBIT Historical Data

The historical data trend for Lonza Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group EBIT Chart

Lonza Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

808.06

983.79

908.80

1,621.94

1,021.05

Lonza Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial															645.23	949.98	584.19	412.81	507.94

Competitive Comparison of Lonza Group's EBIT

For the Diagnostics & Research subindustry, Lonza Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lonza Group's EV-to-EBIT falls into.

Lonza Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $921 Mil.

Lonza Group (OTCPK:LZAGF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Lonza Group's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	1342.582 * ( 1 - 16.46% )	/	( (16827.012	+	17614.679)	/ 2 )
=	1121.5930028	/	17220.8455
=	6.51 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	19481.961	-	726.179	-	( 1928.77	-	max(0, 3194.958	-	5668.363	+	1928.77	))
=	16827.012

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	20008.951	-	137.615	-	( 2256.657	-	max(0, 2918.998	-	5959.946	+	2256.657	))
=	17614.679

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Lonza Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1015.888	/	( ( (7651.48 + max(541.165, 0))	+	(7991.721 + max(957.708, 0)) )	/	2 )
=	1015.888	/	( ( 8192.645	+	8949.429 )	/	2 )
=	1015.888	/	8571.037
=	11.85 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1315.911	+	1832.794	+	324.93)	-	(726.179	+	0	+	2206.291)
=	541.165

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1735.288	+	1917.655	+	50.346)	-	(137.615	+	0	+	2607.966)
=	957.708

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Lonza Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	920.756	/	46767.987
	=	1.97 %

Lonza Group EBIT Related Terms

Thank you for viewing the detailed overview of Lonza Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

LZAGY:USA LONN:Mexico LONNz:UK 0QNO:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland

Address

Muenchensteinerstrasse 38, Basel, CHE, CH-4002

Website

https://www.lonza.com

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.